EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Characteristics, Treatment Patterns, and Survival Outcomes of Cutaneous Angiosarcoma in Japan: A 3‐Year Analysis of the Japan Skin Cancer Registry Study ( JSCaRS )

Hiroshi Kato iD, Fumitaka Ohno, Toshihiko Hoashi iD, Yuki Yamamoto iD, Yasuhiro Fujisawa iD, Eiji Nakano iD, Toshio Ichiki, Shuichi Ohe, Aya Maekawa, Koji Yoshino, Shusuke Yoshikawa iD, Mamiko Masuzawa und 7 weitere

The Journal of Dermatology · 02.11.2026

DOI: 10.1111/1346-8138.70553 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Dermatology, online erschienen am 02.11.2026. Verfasst von Hiroshi Kato und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japanese Skin Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nationwide prospective data on the clinical management of cutaneous angiosarcoma in Japan are lacking. We analyzed 3 years of data from the Japan Skin Cancer Registry Study, a registry involving 86 institutions. Analyses were restricted to the 335 patients registered at least 12 months before the follow‐up data cutoff, a criterion independent of outcome. The median age was 79 years, 66.6% were male, and 74.0% of lesions were located on the scalp. The median tumor diameter was 8.0 cm. At diagnosis, lymph node and distant metastases were present in 14.0% and 12.5%, respectively. Radiotherapy was administered to 78.8%, systemic therapy to 72.8%, and surgery to 14.6%. The most common treatment combination was radiotherapy plus systemic therapy without surgery (54.6%). Median overall survival was 29.0 months, with 1‐ and 2‐year survival rates of 73.8% and 54.8%, respectively. Overall survival was 33.0 months without metastasis, 20.0 months with lymph node metastasis, and 10.0 months with distant metastasis. Distant metastasis (hazard ratio 2.66; 95% confidence interval 1.63–4.33), tumor diameter (1.70 per unit of log‐transformed diameter; 1.30–2.22), and age (1.03 per year; 1.01–1.05) were independent prognostic factors; lymph node metastasis (1.59; 0.96–2.61) and male sex (1.46; 0.96–2.22) were not. Two‐year overall survival was higher in the surgery group (81.5% vs. 49.6%), but was no longer statistically significant after 1:1 propensity score matching (79.7% vs. 61.6%; hazard ratio 0.53; 0.24–1.20), although survival remained numerically higher in the surgery group. The objective response rate to systemic therapy declined from 57.7% in the first line to 23.0% in the second line and 6.7% in the third line. In Japan, cutaneous angiosarcoma is most commonly managed with radiotherapy and taxane‐based systemic therapy rather than surgery. The survival advantage in the unadjusted analysis may partly reflect imbalances in background factors and selection of patients with a favorable prognosis for surgery.

Schlagwörter

Stichwörter der Autor:innen

angiosarcomacombined modality therapypaclitaxelregistriestreatment outcome

Autor:innen und Institutionen

  • Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Department of Dermatology, Kyushu University Graduate School of Medicine, Fukuoka, Japan.
  • Department of Dermatology, Nippon Medical School, Tokyo, Japan.
  • Department of Dermatology, Wakayama Medical University, Wakayama, Japan.
  • Department of Dermatology, Ehime University Graduate School of Medicine, Ehime, Japan.
  • Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.

ORCID-Profile: Hiroshi Kato, Toshihiko Hoashi, Yuki Yamamoto, Yasuhiro Fujisawa, Eiji Nakano, Shusuke Yoshikawa, Ken Horisaki, Tetsuya Magara, Masahito Yasuda, Ayano Maruyama, Kenjiro Namikawa

Förderung

  • Japanese Skin Cancer Society

Zitieren

APA

Kato, H., Ohno, F., Hoashi, T., Yamamoto, Y., Fujisawa, Y., Nakano, E., Ichiki, T., Ohe, S., Maekawa, A., Yoshino, K., Yoshikawa, S., Masuzawa, M., Horisaki, K., Magara, T., Yasuda, M., Maruyama, A., Takahashi, A., Kadono, T., & Namikawa, K. (2026). Clinical Characteristics, Treatment Patterns, and Survival Outcomes of Cutaneous Angiosarcoma in Japan: A 3‐Year Analysis of the Japan Skin Cancer Registry Study ( JSCaRS ). The Journal of Dermatology. https://doi.org/10.1111/1346-8138.70553

Vancouver

Kato H, Ohno F, Hoashi T, Yamamoto Y, Fujisawa Y, Nakano E, et al. Clinical Characteristics, Treatment Patterns, and Survival Outcomes of Cutaneous Angiosarcoma in Japan: A 3‐Year Analysis of the Japan Skin Cancer Registry Study ( JSCaRS ). The Journal of Dermatology. 2026. doi:10.1111/1346-8138.70553

BibTeX
@article{Kato2026,
  author = {Kato, Hiroshi and Ohno, Fumitaka and Hoashi, Toshihiko and Yamamoto, Yuki and Fujisawa, Yasuhiro and Nakano, Eiji and Ichiki, Toshio and Ohe, Shuichi and Maekawa, Aya and Yoshino, Koji and Yoshikawa, Shusuke and Masuzawa, Mamiko and Horisaki, Ken and Magara, Tetsuya and Yasuda, Masahito and Maruyama, Ayano and Takahashi, Akira and Kadono, Takafumi and Namikawa, Kenjiro},
  title = {Clinical Characteristics, Treatment Patterns, and Survival Outcomes of Cutaneous Angiosarcoma in Japan: A 3‐Year Analysis of the Japan Skin Cancer Registry Study ( JSCaRS )},
  journal = {The Journal of Dermatology},
  year = {2026},
  doi = {10.1111/1346-8138.70553}
}
Kostenlos starten →